Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combing Genome-Wide Association Studies and Single-Cell Analysis to Elucidate the Mechanisms of Kidney Disease: Proceedings of the Henry Shavelle Professorship. | Glomerular Dis | 2023 | 38033715 | PubTator, text mining | PubMed |
| Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing of Living Kidney Donors: A Focus Group Study. | Kidney360 | 2023 | 38032814 | PubTator, text mining | PubMed |
| Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options. | Kidney Int Rep | 2023 | 38025220 | PubTator, text mining | PubMed |
| Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma. | Sci Rep | 2023 | 38017264 | PubTator, text mining | PubMed |
| Causes of kidney failure among patients undergoing maintenance hemodialysis in Somalia: a multi-center study. | BMC Nephrol | 2023 | 38012593 | PubTator, text mining | PubMed |
| Attention-based solubility prediction of polysulfide and electrolyte analysis for lithium-sulfur batteries. | Sci Rep | 2023 | 38012171 | PubTator, text mining | PubMed |
| Dairy Intake Modifies the Level of the Bile Acid Precursor and Its Correlation with Serum Proteins Associated with Cholesterol Clearance in Subjects with Hyperinsulinemia. | Nutrients | 2023 | 38004101 | PubTator, text mining | PubMed |
| Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety. | Biomolecules | 2023 | 38002263 | PubTator, text mining | PubMed |
| APOL1-G2 accelerates nephrocyte cell death by inhibiting the autophagy pathway. | Dis Model Mech | 2023 | 37969018 | PubTator, text mining | PubMed |
| Proteomic Determinants of Variation in Cholesterol Efflux: Observations from the Dallas Heart Study. | Int J Mol Sci | 2023 | 37958510 | PubTator, text mining | PubMed |
| Factors associated with chronic kidney disease in patients with diabetes in French Guiana. | Front Clin Diabetes Healthc | 2023 | 37953925 | PubTator, text mining | PubMed |
| An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. | NPJ Syst Biol Appl | 2023 | 37945567 | PubTator, text mining | PubMed |
| Local Inflammation But Not Kidney Cell Infection Associated with High APOL1 Expression in COVID-Associated Nephropathy. | Kidney360 | 2023 | 37927001 | PubTator, text mining | PubMed |
| A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes. | Cell Biosci | 2023 | 37925499 | PubTator, text mining | PubMed |
| Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience. | Can J Kidney Health Dis | 2023 | 37920777 | PubTator, text mining | PubMed |
| Management of traditional risk factors for the development and progression of chronic kidney disease. | Clin Kidney J | 2023 | 37915906 | PubTator, text mining | PubMed |
| Genetic testing in focal segmental glomerulosclerosis: in whom and when? | Clin Kidney J | 2023 | 37915894 | PubTator, text mining | PubMed |
| Relationships among Non-Neoplastic Histopathological Features, Kidney Function, Proteinuria, and Other Clinical Factors in Patients Undergoing Nephrectomy. | Glomerular Dis | 2023 | 37915860 | PubTator, text mining | PubMed |
| Polygenic risk scores for disease risk prediction in Africa: current challenges and future directions. | Genome Med | 2023 | 37904243 | PubTator, text mining | PubMed |
| Achieving quantitative reproducibility in label-free multisite DIA experiments through multirun alignment. | Commun Biol | 2023 | 37903988 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=21